Bank of America’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bank of America’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-155,000	Closed	-$806K	–	7806
2015 Q4	$806K	Sell	155,000 -510,000	-77%	-$2.96M	﹤0.01%	4499
2015 Q3	$4.02M	Buy	+665,000	New	+$8.15M	﹤0.01%	3114
2014 Q4	–	Sell	-9,500	Closed	-$91K	–	8469
2014 Q3	$91K	Sell	9,500 -15,100	-61%	-$154K	﹤0.01%	6085
2014 Q2	$284K	Sell	24,600 -6,900	-22%	-$62.8K	﹤0.01%	5211
2014 Q1	$315K	Buy	31,500 +30,900	+5,150%	+$446K	﹤0.01%	5019
2013 Q4	$8K	Hold	600	–	–	﹤0.01%	7379
2013 Q3	$9K	Buy	+600	New	+$7.19K	﹤0.01%	7228

Bank of America's RPTP Position: Q4 2016 in Review

Bank of America sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 22,877 shares — an estimated $205K sold.

Bank of America first reported a position in RPTP in Q2 2013 and held it in 12 quarters. The position peaked at $883K in Q4 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Bank of America reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Bank of America sold 22,877 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $205K.
Bank of America first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 12 quarters.
Bank of America's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $883K in Q4 2015.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.